All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Compounded Semaglutide Dosage Guide: Complete Guide 2026

The compounded semaglutide dosage guide follows a gradual escalation from 0.25 mg weekly up to 2.4 mg weekly, typically over 16 to 20 weeks. The key...

By Dr. Michael Torres, MD|Reviewed by Dr. David Kim, MD, FACE||

Medically Reviewed

Written by Dr. Michael Torres, MD · Reviewed by Dr. David Kim, MD, FACE

Compounded Semaglutide Dosage Guide: Complete Guide 2026 custom 2026 header image for GLP-1 Weight Loss
Custom header image for Compounded Semaglutide Dosage Guide: Complete Guide 2026, GLP-1 Weight Loss, and better treatment decision-making.
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Search and AI answer brief

Practical answer: Compounded Semaglutide Dosage Guide: Complete Guide 2026

The compounded semaglutide dosage guide follows a gradual escalation from 0.25 mg weekly up to 2.4 mg weekly, typically over 16 to 20 weeks. The key...

Short answer

The compounded semaglutide dosage guide follows a gradual escalation from 0.25 mg weekly up to 2.4 mg weekly, typically over 16 to 20 weeks. The key...

Search intent

This page answers a specific GLP-1 Weight Loss question rather than a generic overview.

What to verify

semaglutide, tirzepatide, retatrutide, cash price and coverage terms

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

The compounded semaglutide dosage guide follows a gradual escalation from 0.25 mg weekly up to 2.4 mg weekly, typically over 16 to 20 weeks. The key...

The compounded semaglutide dosage guide follows a gradual escalation from 0.25 mg weekly up to 2.4 mg weekly, typically over 16 to 20 weeks. The key advantage of compounded semaglutide over brand-name products is dosing flexibility: your provider can prescribe custom increments to minimize side effects while maximizing weight loss at every stage.

Key Takeaways

  • Start at 0.25 mg weekly for 4 weeks, then increase by 0.25 mg or 0.5 mg increments every 4 weeks based on tolerance.
  • The standard target maintenance dose for weight loss is 2.0 to 2.4 mg weekly, though many patients see strong results at 1.0 to 1.5 mg.
  • Compounded vials allow custom doses (e.g., 0.375 mg, 0.75 mg, 1.25 mg) that brand-name pens can't deliver.
  • Rushing the dose escalation is the most common cause of severe GI side effects. Patience pays off.
  • Vial concentrations vary (typically 1 mg/mL to 5 mg/mL), so reading your vial label carefully is important for accurate dosing.
  • FormBlends provides individualized dosing protocols with regular check-ins to improve your response.

Overview: Why Dose Escalation Matters

Semaglutide isn't a medication you start at full strength. The gradual dose increase serves two critical purposes: For a complete cost breakdown, see our compare semaglutide prices.

GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Illustration for Compounded Semaglutide Dosage Guide: Complete Guide 2026
  1. GI tolerance. Your digestive system needs time to adjust to slowed gastric emptying. Starting at a full therapeutic dose would cause severe nausea, vomiting, and diarrhea in most patients.
  2. Receptor sensitization. GLP-1 receptors in the brain and gut gradually become more responsive to semaglutide over weeks. A lower starting dose allows your body to develop the appetite-suppressing response smoothly.

Patients who try to accelerate the schedule or start at higher doses almost universally regret it. The GI side effects at too-high doses can be severe enough to cause dehydration, emergency room visits, and ultimately treatment discontinuation. The slow approach produces better adherence and better long-term results .

Standard Dosing Schedule

Standard Compounded Semaglutide Dose Escalation
Week Weekly Dose Phase Expected Effects
1 to 4 0.25 mg Initiation Mild appetite changes, body adjusting, possible light nausea
5 to 8 0.5 mg Low therapeutic Noticeable appetite suppression, 1 to 2 lbs/week loss begins
9 to 12 1.0 mg Therapeutic Strong appetite control, steady weight loss, food noise significantly reduced
13 to 16 1.5 mg Enhanced Peak weight loss rate for many patients
17 to 20 2.0 mg High therapeutic Maximum appetite suppression for most patients
21+ 2.4 mg Maximum Highest approved dose equivalent (Wegovy dosing)

This schedule mirrors the Wegovy escalation protocol. Your provider may modify it based on your individual response, tolerance, and goals.

Get compounded semaglutide from $99/mo

Free provider review, personalized dosing, and ongoing support included.

Start Free Assessment →

Custom Dosing: The Compounded Advantage

One of the primary benefits of compounded semaglutide is the ability to dial in custom doses that brand-name products don't offer. Brand-name Ozempic comes in fixed doses of 0.25 mg, 0.5 mg, 1.0 mg, and 2.0 mg. Wegovy offers 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg. There are no in-between options.

With compounded semaglutide from a vial, your provider can prescribe any dose by adjusting the injection volume. Common custom doses include:

  • 0.375 mg: A midpoint between 0.25 mg and 0.5 mg for patients who experience significant nausea at 0.5 mg.
  • 0.75 mg: An intermediate step between 0.5 mg and 1.0 mg for patients who need a slower escalation.
  • 1.25 mg: A gentle step up from 1.0 mg rather than jumping to 1.5 mg or 1.7 mg.
  • 1.75 mg: A bridge dose between 1.5 mg and 2.0 mg.

This granularity allows providers to keep patients progressing while minimizing the side effect spikes that often accompany the larger jumps in brand-name escalation schedules.

How Vial Concentrations

Compounded semaglutide comes in multi-dose vials at various concentrations. Understanding your vial's concentration is important for drawing the correct dose.

Common Compounded Semaglutide Vial Concentrations
Concentration Volume for 0.25 mg Dose Volume for 0.5 mg Dose Volume for 1.0 mg Dose Volume for 2.0 mg Dose
1 mg/mL 0.25 mL (25 units) 0.50 mL (50 units) 1.00 mL (100 units) Not practical
2 mg/mL 0.125 mL (12.5 units) 0.25 mL (25 units) 0.50 mL (50 units) 1.00 mL (100 units)
2.5 mg/mL 0.10 mL (10 units) 0.20 mL (20 units) 0.40 mL (40 units) 0.80 mL (80 units)
5 mg/mL 0.05 mL (5 units) 0.10 mL (10 units) 0.20 mL (20 units) 0.40 mL (40 units)

Important notes:

  • Standard insulin syringes are marked in "units" where 100 units = 1 mL.
  • Higher concentration vials require smaller injection volumes, which can be more comfortable but demand more precision when drawing up.
  • Always verify your vial's concentration on the label before drawing your dose. If you receive a new vial with a different concentration, recalculate your injection volume.
  • When in doubt, contact your provider or pharmacist. Dosing errors with concentrated vials can mean receiving 2 to 5 times the intended dose.

How to Draw and Inject Your Dose

  1. Wash your hands thoroughly with soap and water.
  2. Check your vial. Verify the concentration on the label. The solution should be clear and colorless. Don't use if cloudy, discolored, or containing particles.
  3. Clean the vial top with an alcohol swab. Let it dry.
  4. Draw up your dose. Using an insulin syringe, pull back the plunger to the correct volume for your prescribed dose. Insert the needle into the vial, push air in, then invert the vial and slowly draw out the medication.
  5. Remove air bubbles. Tap the syringe gently to move bubbles to the top, then push the plunger slightly to expel them.
  6. Choose your injection site. Abdomen (2+ inches from navel), thigh (front or outer), or upper arm (back). Rotate sites each week.
  7. Clean the injection site with an alcohol swab. Let it dry completely.
  8. Pinch the skin, insert the needle at a 45 to 90 degree angle, and push the plunger steadily.
  9. Hold for 5 to 10 seconds after fully depressing the plunger before withdrawing the needle.
  10. Don't rub the injection site. Apply gentle pressure with a cotton ball if needed.
  11. Dispose of the syringe in a sharps container.

When to Increase, Pause, or Decrease Your Dose

Signs It Is Time to Increase

  • You have been at your current dose for at least 4 weeks
  • GI side effects have resolved or are minimal
  • Appetite suppression is wearing off before the next injection day
  • Weight loss has stalled for 3+ weeks despite consistent diet and exercise

Signs to Pause at Your Current Dose

  • You're still experiencing moderate nausea or GI effects
  • Weight loss is steady (1 to 2 lbs/week) at your current dose
  • You feel good and don't need stronger appetite suppression

Signs to Decrease or Hold

  • Severe nausea or vomiting lasting more than 3 days
  • Unable to eat or stay hydrated
  • Losing weight too rapidly (more than 3 lbs/week consistently)
  • Significant fatigue, dizziness, or weakness

Your provider should be making these decisions with you, not leaving you to guess. Regular check-ins (at minimum monthly) ensure your dose matches your body's current needs.

Storage and Handling

  • Unopened vials: Refrigerate at 36 to 46 degrees F (2 to 8 degrees C). Don't freeze.
  • Opened (in-use) vials: Refrigerate between uses. Most compounded semaglutide has a beyond-use date of 28 to 90 days after compounding, printed on the label.
  • Temperature excursions: Brief exposure to room temperature (during injection) is fine. Avoid leaving vials in hot cars, direct sunlight, or near heat sources.
  • Syringes: Store unused syringes at room temperature in their sterile packaging. Never reuse syringes.
  • Travel: Use an insulated bag with a cold pack when traveling. TSA allows insulin syringes and medication vials with proper labeling.

Dosing Mistakes and How to Handle Them

Common Dosing Situations
Situation What to Do
Missed a weekly dose (less than 5 days late) Take it as soon as you remember, then resume your regular schedule
Missed a weekly dose (5+ days late) Skip the missed dose, take your next dose on your regular day
Accidentally injected too much Monitor for symptoms (nausea, vomiting). Contact your provider. Seek emergency care if you experience severe symptoms.
Injected too little Don't re-inject. Take your full dose at the next scheduled time
Unsure if full dose was delivered (air bubble, leaking) Don't re-inject. Monitor your response and take your full dose at the next scheduled time
Injected into muscle instead of fat This isn't dangerous but may cause more soreness. Aim for a shallower angle next time.

Frequently Asked Questions

What dose of compounded semaglutide is most effective for weight loss?

Most patients see the strongest weight loss at 1.0 to 2.4 mg weekly. The STEP 1 trial[1] showed that 2.4 mg weekly produced an average of 14.9% body weight[1] loss over 68 weeks. But some patients achieve excellent results at lower doses. Your provider will help determine the lowest effective dose for your goals.

Can I stay on a lower dose if it's working?

Absolutely. If you're losing weight steadily and tolerating a lower dose well, there's no requirement to escalate to the maximum. Some patients maintain on 1.0 mg or 1.5 mg indefinitely with excellent results.

How do I know if my dose is too high?

Persistent nausea lasting more than 2 weeks, inability to eat adequate protein, severe fatigue, or losing weight faster than 3 pounds per week consistently may indicate your dose is too high. Contact your provider to discuss a reduction.

What if I want to increase my dose faster?

We strongly advise against accelerating the escalation schedule. Faster escalation leads to more severe side effects, higher dropout rates, and no better long-term weight loss. Trust the gradual approach.

Is the dosing the same as Ozempic or Wegovy?

The milligram amounts are the same, and the general escalation principle is the same. The main difference is that compounded semaglutide allows for intermediate doses that brand-name pens can't deliver, giving your provider more flexibility to customize your escalation.

How long will one vial last?

This depends on the vial size, concentration, and your dose. A typical 2 mL vial at 2.5 mg/mL contains 5 mg total, which lasts 20 weeks at the 0.25 mg starting dose but only 2.5 weeks at the 2.0 mg dose. Your pharmacy should provide enough medication to cover your prescribed dose for the dispensing period (usually 4 to 8 weeks).

Medical References

  1. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. [PubMed | ClinicalTrials.gov | DOI]

Get Personalized Dosing Support

Compounded semaglutide dosing isn't one-size-fits-all. At FormBlends, our physicians create individualized dosing protocols, adjust your schedule based on your response, and ensure you're getting the right amount of medication at every stage. Safe, effective dosing requires professional guidance.

Research Snapshot

Provider comparison
Page type
Provider comparison
FormBlends review
Last reviewed
2026-04-01
FormBlends review
FormBlends official source
Official source
Ozempic evidence source
Official source
Retatrutide evidence source
Official source
Semaglutide evidence source
Official source
Tirzepatide evidence source
Official source
Wegovy evidence source
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For Compounded Semaglutide Dosage Guide: Complete Guide 2026, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Randomized trialSemaglutide evidence2021

Once-Weekly Semaglutide in Adults with Overweight or Obesity

Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.

PubMed

Randomized trialSemaglutide evidence2021

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance

Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.

PubMed

Randomized trialSemaglutide evidence2022

Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight

Supports head-to-head context when pages compare older and newer GLP-1 options.

PubMed

Systematic reviewGLP-1 class evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.

PubMed

Systematic reviewGLP-1 class evidence2025

Discontinuing glucagon-like peptide-1 receptor agonists and body habitus

Used for pages discussing stopping therapy, weight regain, and long-term planning.

PubMed

Systematic reviewGLP-1 class evidence2025

Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition

Supports body-composition, lean-mass, and metabolic-risk context.

PubMed

Systematic reviewObesity pharmacotherapy evidence2025

Emerging pharmacotherapies for obesity: A systematic review

Broad context for new and established obesity-drug categories.

PubMed

ReviewObesity pharmacotherapy evidence2026

Glucagon-like receptor agonists and next-generation incretin-based medications

Current review for incretin-based obesity medications and cardiometabolic effects.

PubMed

Systematic reviewObesity pharmacotherapy evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

Used as a class-level evidence anchor when no more specific citation group matches.

PubMed

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Direct answer

Compounded Semaglutide Dosage Guide: Complete Guide 2026 research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

FormBlends Editorial Context

Reviewed May 14, 2026

The compounded semaglutide dosage guide follows a gradual escalation from 0.25 mg weekly up to 2.4 mg weekly, typically over 16 to 20 weeks. The key. "Compounded Semaglutide Dosage Guide: Complete Guide 2026" is most useful when you treat it as decision prep, not a shortcut. The page is built around dosing literacy and clinician follow-up, with the highest-value checks sitting around semaglutide, dosing, safety and pharmacy quality. Because this article has 11 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. If the answer affects treatment, cost, pharmacy choice, or dosing, bring the specifics to a licensed clinician before acting.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Verify the pharmacy pathway, certificate of analysis, sterility testing, and clinician oversight before trusting a source.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for Compounded Semaglutide Dosage Guide

For this glp-1 weight loss page, the 2026 refresh focuses on semaglutide, tirzepatide, retatrutide, cash-pay pricing, safety signals, compounded so the article stays close to the question behind "Compounded Semaglutide Dosage Guide".

The useful details are the practical ones: what to verify, what changes risk or cost, and which details separate Compounded Semaglutide Dosage Guide from nearby GLP-1, peptide, hormone, or provider-comparison searches.

Readers can use the added context to bring sharper questions to a licensed provider before making a treatment, cost, or care decision.

Compounded Semaglutide Dosage Guide custom 2026 image for glp-1 weight loss on FormBlends

Custom 2026 image for Compounded Semaglutide Dosage Guide, glp-1 weight loss, and better treatment decision-making.

Image description: Unique image for this page covering Compounded Semaglutide Dosage Guide, glp-1 weight loss, safety, cost, provider selection, and patient decision-making.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by Dr. Michael Torres, MD

Endocrinologist. This article was researched against primary regulatory, trial, prescribing, and manufacturer sources where available. Reviewed by Dr. David Kim, MD, FACE for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.